Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedA notice announces NIH’s website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.4%

- Check31 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0; the study record history is unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer now displays Revision: v3.7.0, replacing the previous v3.6.6. This reflects a site version update but does not change the study information presented.SummaryDifference0.1%

- Check80 days agoChange DetectedNew revision stamp 'Revision: v3.6.6' is added to the history. The previous 'Revision: v3.6.5' entry is removed.SummaryDifference0.1%

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.